<!doctype html>
<html lang="en-gb">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <title>Hereditary Epidermolysis Bullosa Information</title>
  <link rel="stylesheet" href="css/bootstrap.min.css" />
  <link rel="stylesheet" href="css/styles.css" />
  <style>
    /* Add top margin to move the content down */
    #content {
        margin-top: 100px; /* Adjust this value to control the distance moved downward */
    }
    /* Increase the distance between the button and the footer */
    .btn-primary {
        margin-bottom: 50px; /* Adjust this value to control the distance between the button and the footer */
    }
  </style>
</head>

<body>
<header class="header">
<div id="overview" class="container">
  <nav class="navbar navbar-inverse" role="navigation">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#main-nav">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a href="index.html" class="navbar-brand logo"><b>Rare<i>Insight</i></b></a>
    </div>
    <div id="main-nav" class="collapse navbar-collapse">
      <ul class="nav navbar-nav">
        <li class="active" id="firstLink"><a href="bullous-pemphigoid.html" class="scroll-link">Overview</a></li>
        <li><a href="#articles" class="scroll-link">Articles</a></li>
        <li><a href="#team" class="scroll-link">Hospitals & Specialists</a></li>
        <li><a href="#groups" class="scroll-link">Patient Groups & Foundations</a></li>
        <li><a href="index.html" class="scroll-link">Back to Home</a></li>
      </ul>
    </div>
  </nav>
</div>
</header>
<section id="content">
<div class="container">
  <div class="row">
    <div class="col-md-12">
      <br/>
      <br/>
      <h2 class="text-center">Bullous Pemphigoid</h2>
      <br/>
      <p><strong>Bullous Pemphigoid is a chronic autoimmune skin disorder that causes large, fluid-filled blisters on areas of skin that often flex, such as the arms, legs, and abdomen. It occurs when the immune system mistakenly attacks the skinâ€™s basement membrane, leading to separation of skin layers and blister formation, typically in older adults.</strong></p> 
      <br/> 
      
      <h3><b>Symptoms</b></h3>
      <p><strong>Symptoms of Bullous Pemphigoid include:</strong></p>
      <ul>
        <li>Large, tense blisters filled with clear fluid</li>
        <li>Red or itchy rash before blisters appear</li>
        <li>Blisters typically form on the arms, legs, abdomen, or groin</li>
        <li>Skin around blisters may be inflamed or painful</li>
        <li>In some cases, mouth or eye sores may occur</li>
      </ul>

      <h3><b>Types of Bullous Pemphigoid</b></h3>
      <p><strong>Bullous pemphigoid is primarily classified based on the location and appearance of the blisters:</strong></p>
      <ul>
        <li>Generalized Bullous Pemphigoid: The most common type, featuring widespread, tense blisters mainly on the arms, legs, and trunk.</li>
        <li>Localized Bullous Pemphigoid: Blisters appear in specific areas, often around wounds or areas of pressure.</li>
        <li>Mucous Membrane Pemphigoid (a related condition): Involves the mucous membranes, such as the mouth, eyes, or genitals, and can lead to scarring.</li>
        <li>Non-Bullous Pemphigoid: In some cases, patients experience intense itching and red patches without visible blisters.</li>
      </ul>

      <h3><b>Causes</b></h3>
      <p>Bullous Pemphigoid is an autoimmune disorder caused by the immune system mistakenly attacking proteins that connect the outer layer of skin (epidermis) to the underlying layer (dermis). This immune response leads to inflammation and blister formation. It is not inherited and typically occurs in older adults, often without a known trigger, though certain medications or skin injuries may increase risk.</p>

      <h3><b>Prevention and Care</b></h3>
      <p>As an autoimmune condition, Bullous Pemphigoid cannot be fully prevented, but flare-ups can be managed. Avoiding skin trauma, using gentle skincare products, and wearing loose-fitting clothing can help reduce blister formation. Treatment often includes corticosteroids or immunosuppressants, and regular follow-up with a dermatologist is important to control symptoms and prevent complications.</p>
      <br/>
      <br/>
      <br/>
    </div>
  </div>
</div>
</section>

<!-- Articles Section -->
<section id="articles">
<div class="container">
  <br/>
  <br/>
  <br/>
  <div class="heading text-center">
    <h2>Articles</h2>
    <p>Read the latest articles on Bullous Pemphigoid and related topics</p>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://www.ncbi.nlm.nih.gov/books/NBK535374/" class="special-link"><b>Bullous Pemphigoid</b></a></h4>
      <p>Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder, representing 80% of subepidermal immunobullous cases. It most commonly affects elderly patients between the ages of 60 and 80. This activity reviews the etiology, presentation, evaluation, and management of bullous pemphigoid and the interprofessional team's role in evaluating, diagnosing, and managing the condition.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6486083/" class="special-link"><b>Bullous Pemphigoid</b></a></h4>
      <p>Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, drug-induced cases and improvement in the diagnosis of the nonbullous presentations of the disease. A dysregulated T cell immune response and synthesis of IgG and IgE autoantibodies against hemidesmosomal proteins (BP180 and BP230) lead to neutrophil chemotaxis and degradation of the basement membrane zone. </p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://pubmed.ncbi.nlm.nih.gov/36578049/" class="special-link"><b>Insights into bullous pemphigoid: A comprehensive review of diagnostic modalities</b></a></h4>
      <p>Bullous pemphigoid (BP) is an autoimmune blistering disorder associated with profound morbidity. Timely diagnosis of BP is critical for early initiation of therapies, but diagnosis of BP is often challenging. As the pathophysiology of BP has been further elucidated, new diagnostic modalities have been developed. However, it remains unclear which modalities are the most effective for diagnosing BP.</p>
    </div>
  </div>
  <br/>
  <br/>
  <br/>
</div>
</section>

<!-- Doctors Section -->
<section id="team" class="page-section">
  <div class="container">
    <br/>
    <br/>
    <br/>
    <div class="heading text-center"> 
      <!-- Heading -->
      <h2>Hospital and Specialists</h2>
    </div>
    <br/>
    <!-- Doctor's Details -->
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>CDr. Victoria P. Werth, MD</h3>
        <h4>Renowned dermatologist and immunologist specializing in autoimmune blistering diseases; Professor at the University of Pennsylvania.</h4>
        <h4>Hospital of the University of Pennsylvania</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Chief, Dermatology, Philadelphia V.A. Hospital</li>
          <li>Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center</li>
          <li>Professor of Dermatology in Medicine</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://www.pennmedicine.org/providers/victoria-werth">More Information</a></h4>
          <h4><a href="https://www.pennmedicine.org/locations/hospital-of-the-university-of-pennsylvania">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/werth_victoria.jpg" alt="" width="100%"> </div>
    </div>
    
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>Dr. Robert G. Micheletti, MD</h3>
        <h4>Chief of Hospital Dermatology and Director of the Cutaneous Vasculitis Clinic at Penn Medicine; expert in autoimmune skin disorders.</h4>
        <h4>Pennsylvania Hospital</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Chief of Hospital Dermatology</li>
          <li>Chief of Dermatology, Pennsylvania Hospital</li>
          <li>Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center</li>
          <li>Director, Dermatology Medical Student Elective</li>
          <li>Associate Professor of Dermatology at the Hospital of the University of Pennsylvania</li>
          <li>Associate Professor of Dermatology in Medicine (General Internal Medicine)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://www.pennmedicine.org/providers/robert-micheletti">More Information</a></h4>
          <h4><a href="https://www.pennmedicine.org/locations/pennsylvania-hospital">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/micheletti_robert.jpg" alt="" width="100%"> </div>
    </div>
    
    <div class="row feature design">
      <div class="area1 columns right">
        <h3>Dr. Misha Rosenbach, MD</h3>
        <h4>Vice Chair of Education and Director of the Cutaneous Sarcoidosis & Granulomatous Disease Clinic at Penn Medicine; specializes in complex dermatologic conditions.</h4>
        <h4>Hospital of the University of Pennsylvania</h4>
        <br/>
        <h4>Past Experiences:</h4> 
        <ul>
          <li>Vice Chair, Education</li>
          <li>Director, Cutaneous Sarcoidosis & Granulomatous Disease Clinic</li>
          <li>Dermatology Residency Program Director</li>
          <li>Paul R. Gross Professor of Dermatology</li>
          <li>Professor of Dermatology in Medicine (Rheumatology)</li>
        </ul>
        <br/>
        <div class="row">
          <h4><a href="https://www.pennmedicine.org/providers/misha-rosenbach">More Information</a></h4>
          <h4><a href="https://www.pennmedicine.org/locations/hospital-of-the-university-of-pennsylvania">Hospital Information</a></h4></div>
        </div>
      <div class="area2 columns feature-media left"> <img src="images/rosenbach_misha.jpg" alt="" width="160%"> </div>
    </div>
    <br/>
    <br/>
    <br/>
  </div>
  <!--/.container--> 
</section>

<!-- Function Section -->
<section id="groups">
<div class="container">
  <br/>
  <br/>
  <div class="heading text-center">
    <!-- Heading -->
    <h2>Patient Groups & Foundations</h2>
  </div>
  <div class="row">
    <div class="col-md-4">
      <h4><a href="https://www.eb-researchnetwork.org/about-us/network-partners/" class="special-link"><b>EB Research Network</b></a></h4>
      <p>The EB Research Network is a collaborative global network of organizations, researchers, and advocates working together to advance research and find treatments for Epidermolysis Bullosa.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="https://www.debra.org/" class="special-link"><b>Debra of America</b></a></h4>
      <p>Debra of America is a nonprofit organization dedicated to supporting people affected by Epidermolysis Bullosa (EB) through advocacy, research funding, and resources for individuals and families.</p>
    </div>
    <div class="col-md-4">
      <h4><a href="http://www.eb.org.tw/ap/index.aspx " class="special-link"><b>Taiwan EB Association</b></a></h4>
      <p>The EB Association Taiwan is dedicated to improving the lives of individuals affected by Epidermolysis Bullosa (EB) in Taiwan through advocacy, support services, and raising awareness of this rare genetic condition.</p>
    </div>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    <br/>
    
    <a href="index.html" class="btn btn-primary">Back to Home</a>
  </div>
</div>
</section>

<footer>
<div class="container text-center">
  <p>&copy; 2024 RareInsight. All rights reserved.</p>
</div>
</footer>

<script src="js/jquery-1.8.
